Orient Bio Inc
KRX:002630

Watchlist Manager
Orient Bio Inc Logo
Orient Bio Inc
KRX:002630
Watchlist
Price: 642 KRW -0.31%
Market Cap: 76.1B KRW

Orient Bio Inc
Net Income (Common)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Orient Bio Inc
Net Income (Common) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Orient Bio Inc
KRX:002630
Net Income (Common)
-₩8.5B
CAGR 3-Years
N/A
CAGR 5-Years
4%
CAGR 10-Years
-13%
Samsung Biologics Co Ltd
KRX:207940
Net Income (Common)
₩1.6T
CAGR 3-Years
47%
CAGR 5-Years
35%
CAGR 10-Years
N/A
S
ST Pharm Co Ltd
KOSDAQ:237690
Net Income (Common)
₩33.9B
CAGR 3-Years
60%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
F
FutureChem Co Ltd
KOSDAQ:220100
Net Income (Common)
-₩3.9B
CAGR 3-Years
23%
CAGR 5-Years
17%
CAGR 10-Years
N/A
L
LegoChem Biosciences Inc
KOSDAQ:141080
Net Income (Common)
₩1.8B
CAGR 3-Years
N/A
CAGR 5-Years
-36%
CAGR 10-Years
N/A
M
Macrogen Inc
KOSDAQ:038290
Net Income (Common)
-₩6.3B
CAGR 3-Years
N/A
CAGR 5-Years
21%
CAGR 10-Years
N/A
No Stocks Found

Orient Bio Inc
Glance View

ORIENTBIO, Inc. engages in the research and development of biotechnology. The company is headquartered in Seongnam, Gyeonggi-Do and currently employs 104 full-time employees. The firm produces and supplies laboratory animals, including mice, rats, guinea pigs, hamsters, specific pathogen free (SPF) rabbits, beagles and others. The company also provides contract research organization (CRO) services, including CRO safety assessment and CRO new drug development services; medical and library equipment, such as barrier systems, and support services such as rodent surgery services, laboratory diagnostics services, transgenic services, genetic testing services and other services. In addition, along with its subsidiaries, the Company provides feeds, reagents, disinfectants, automobile components, power supply equipment, and other machines.

Orient Bio Inc Intrinsic Value
HIDDEN
Show

See Also

What is Orient Bio Inc's Net Income (Common)?
Net Income (Common)
-8.5B KRW

Based on the financial report for Jun 30, 2025, Orient Bio Inc's Net Income (Common) amounts to -8.5B KRW.

What is Orient Bio Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
-13%

Back to Top